Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Chidamide |
| Trade Name | |
| Synonyms | CS055|HBI-8000|Epidaza|Tucidinostat |
| Drug Descriptions |
Chidamide (tucidinostat) is an HDAC inhibitor, which may lead to increased apoptosis and decreased proliferation of tumor cells (PMID: 25384499, PMID: 32855355, PMID: 32801749). |
| DrugClasses | HDAC Inhibitor 45 |
| CAS Registry Number | 1616493-44-7 |
| NCIT ID | C97263 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Bevacizumab + Chidamide + Sintilimab | Bevacizumab Chidamide Sintilimab | 0 | 0 |
| Chidamide | Chidamide | 0 | 0 |
| Chidamide + Exemestane | Chidamide Exemestane | 0 | 0 |
| Chidamide + Nivolumab | Chidamide Nivolumab | 0 | 2 |
| Chidamide + Pembrolizumab | Chidamide Pembrolizumab | 0 | 1 |